Literature DB >> 17366345

Potential genetic variants in schizophrenia: a Bayesian analysis.

Håkan Hall1, Glenn Lawyer, Anna Sillén, Erik G Jönsson, Ingrid Agartz, Lars Terenius, Stefan Arnborg.   

Abstract

A number of different gene polymorphisms have been found to dispose for the development of schizophrenia. However, no single gene polymorphism is sufficient for the precipitation of schizophrenia. Swedish psychosis patients (n=103) and control subjects (n=89) were analyzed for 36 single nucleotide polymorphisms in 30 candidate genes for schizophrenia. Evidence of association was analyzed with Bayesian statistical methods. Variants in the genes coding for dopamine-D2 receptor, brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), neuregulin 1, reelin and synapsin 3 showed association with schizophrenia, although few subjects were found in the minority allele for the two latter variants. The six gene variants, all with suspected connection to schizophrenia, were found to be risk factors when considered in combination, but not separately. The results indicate that the Bayesian statistical method gives additional possibilities in the search for risk factors for schizophrenia or other complex disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366345     DOI: 10.1080/15622970600892004

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  12 in total

1.  Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect.

Authors:  Wolfgang H Sommer; Jessica Lidström; Hui Sun; Derek Passer; Robert Eskay; Stephen C J Parker; Stephanie H Witt; Ulrich S Zimmermann; Vanessa Nieratschker; Marcella Rietschel; Elliott H Margulies; Miklós Palkovits; Manfred Laucht; Markus Heilig
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

Review 2.  Synapsin III: role in neuronal plasticity and disease.

Authors:  Barbara Porton; William C Wetsel; Hung-Teh Kao
Journal:  Semin Cell Dev Biol       Date:  2011-07-30       Impact factor: 7.727

Review 3.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

Review 4.  Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.

Authors:  Andrea Schmitt; Eleni Parlapani; Oliver Gruber; Thomas Wobrock; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

5.  Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.

Authors:  For-Wey Lung; Bih-Ching Shu; Wei-Tsung Kao; C Nathan Chen; Yu-Chi Ku; Dong-Sheng Tzeng
Journal:  BMC Med Genet       Date:  2009-12-29       Impact factor: 2.103

6.  Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.

Authors:  Ripu D Jindal; Anil K Pillai; Sahebrao P Mahadik; Kevin Eklund; Debra M Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2010-01-21       Impact factor: 4.939

7.  Neuregulin 1 genotype and schizophrenia.

Authors:  Marcus R Munafò; Angela S Attwood; Jonathan Flint
Journal:  Schizophr Bull       Date:  2007-11-20       Impact factor: 9.306

Review 8.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

9.  Synapsin III acts downstream of semaphorin 3A/CDK5 signaling to regulate radial migration and orientation of pyramidal neurons in vivo.

Authors:  Laura E Perlini; Joanna Szczurkowska; Bryan A Ballif; Alessandra Piccini; Silvio Sacchetti; Silvia Giovedì; Fabio Benfenati; Laura Cancedda
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

10.  Association between Interleukin-10 Gene Promoter Haplotype and Schizophrenia in a Han-Chinese Study.

Authors:  Hsin-Yi Peng; Yu-Chi Ku; Bih-Ching Shu; For-Wey Lung
Journal:  Int J Biomed Sci       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.